Treatment of serpiginous choroiditis with intravitreous fluocinolone acetonide implant

Rajeev K. Seth; Paul A. Gaudio

doi:10.1080/09273940802023778

Treatment of serpiginous choroiditis with intravitreous fluocinolone acetonide implant

Rajeev K. Seth, Paul A. Gaudio

Research output: Contribution to journal › Article › peer-review

14 Scopus citations

Abstract

Purpose: To describe a case in which a fluocinolone acetonide implant was used in a patient with serpiginous choroiditis. Design: Case report. Results: A 57-year-old woman with active serpiginous choroiditis threatening the fovea of her right eye received one intravitreous triamcinolone acetonide injection, leading to immediate disease control. An intravitreous fluocinolone acetonide implant was placed, and resulted in ongoing control of the disease as of her 14 months postoperative follow-up. Conclusions: Intravitreous fluocinolone acetonide implant should be recognized as a potential treatment option for serpiginous choroiditis.

Original language	English (US)
Pages (from-to)	103-105
Number of pages	3
Journal	Ocular Immunology and Inflammation
Volume	16
Issue number	3
DOIs	https://doi.org/10.1080/09273940802023778
State	Published - May 2008
Externally published	Yes

Keywords

Fluocinolone acetonide
Intravitreous implant
Retisert
Serpiginous choroiditis
Triamcinolone acetonide

ASJC Scopus subject areas

Immunology and Allergy
Ophthalmology

Access to Document

10.1080/09273940802023778

Cite this

@article{17c2a5762d674c15884f465eaf449271,

title = "Treatment of serpiginous choroiditis with intravitreous fluocinolone acetonide implant",

abstract = "Purpose: To describe a case in which a fluocinolone acetonide implant was used in a patient with serpiginous choroiditis. Design: Case report. Results: A 57-year-old woman with active serpiginous choroiditis threatening the fovea of her right eye received one intravitreous triamcinolone acetonide injection, leading to immediate disease control. An intravitreous fluocinolone acetonide implant was placed, and resulted in ongoing control of the disease as of her 14 months postoperative follow-up. Conclusions: Intravitreous fluocinolone acetonide implant should be recognized as a potential treatment option for serpiginous choroiditis.",

keywords = "Fluocinolone acetonide, Intravitreous implant, Retisert, Serpiginous choroiditis, Triamcinolone acetonide",

author = "Seth, {Rajeev K.} and Gaudio, {Paul A.}",

year = "2008",

month = may,

doi = "10.1080/09273940802023778",

language = "English (US)",

volume = "16",

pages = "103--105",

journal = "Ocular Immunology and Inflammation",

issn = "0927-3948",

publisher = "Informa Healthcare",

number = "3",

}

TY - JOUR

T1 - Treatment of serpiginous choroiditis with intravitreous fluocinolone acetonide implant

AU - Seth, Rajeev K.

AU - Gaudio, Paul A.

PY - 2008/5

Y1 - 2008/5

N2 - Purpose: To describe a case in which a fluocinolone acetonide implant was used in a patient with serpiginous choroiditis. Design: Case report. Results: A 57-year-old woman with active serpiginous choroiditis threatening the fovea of her right eye received one intravitreous triamcinolone acetonide injection, leading to immediate disease control. An intravitreous fluocinolone acetonide implant was placed, and resulted in ongoing control of the disease as of her 14 months postoperative follow-up. Conclusions: Intravitreous fluocinolone acetonide implant should be recognized as a potential treatment option for serpiginous choroiditis.

AB - Purpose: To describe a case in which a fluocinolone acetonide implant was used in a patient with serpiginous choroiditis. Design: Case report. Results: A 57-year-old woman with active serpiginous choroiditis threatening the fovea of her right eye received one intravitreous triamcinolone acetonide injection, leading to immediate disease control. An intravitreous fluocinolone acetonide implant was placed, and resulted in ongoing control of the disease as of her 14 months postoperative follow-up. Conclusions: Intravitreous fluocinolone acetonide implant should be recognized as a potential treatment option for serpiginous choroiditis.

KW - Fluocinolone acetonide

KW - Intravitreous implant

KW - Retisert

KW - Serpiginous choroiditis

KW - Triamcinolone acetonide

UR - http://www.scopus.com/inward/record.url?scp=45749100060&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=45749100060&partnerID=8YFLogxK

U2 - 10.1080/09273940802023778

DO - 10.1080/09273940802023778

M3 - Article

C2 - 18569797

AN - SCOPUS:45749100060

SN - 0927-3948

VL - 16

SP - 103

EP - 105

JO - Ocular Immunology and Inflammation

JF - Ocular Immunology and Inflammation

IS - 3

ER -

Treatment of serpiginous choroiditis with intravitreous fluocinolone acetonide implant

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this